MindScape Ketamine & Infusion Therapy seeks patients for clinical study focusing on depression


MindScape Ketamine & Infusion Therapy from Houston, Texas, is asking applicants suffering from depression to sign up for the free clinical study. It is the only clinic in Houston to offer VR-based guided meditation to complement clinically proven intravenous ketamine treatments. The clinic believes that its innovative use of virtual reality significantly enhances the beneficial effects of intravenous ketamine.

A MindScape spokesperson says about the new study: “Ketamine has been studied extensively in the medical literature and its effectiveness in helping people with treatment-resistant depression has been validated by rigorous research. Even the patients we helped here at MindScape report amazing results after undergoing ketamine treatments. Intravenously.The scientific community has already recognized the potential of ketamine as a possible solution for treating conditions such as major depression, bipolar depressionanxiety disorders, obsessive-compulsive disorder, post-traumatic stress disorder, psychiatric disorders, and chronic pain. However, the search for scientific truth is endless and there are still many possible ways to improve ketamine treatment methodologies. This clinical study was designed to answer questions that add further clarity to the mechanism behind intravenous ketamine treatments. As part of the study, applicants will be offered treatment free of charge and their feedback will be used to improve clinic services while advancing the science and conversation surrounding ketamine use into the future. Please consider signing up as we are confident that you will appreciate the benefits of the treatment. By participating in the study, you will also take the satisfaction of knowing that the lessons learned from your treatment will be used to improve the lives of countless people suffering from depression.”

Therapy with the help of virtual reality

Therapy with the help of virtual reality

Depression is a global phenomenon. According to statistics highlighted by MindScape in a post on its Facebook page, it is estimated that about 3.5% of the world’s population suffers from depression, and in the United States approximately 20 million people go through at least one depressive episode each year. Notable symptoms of depression include chronically sad, anxious or “empty” moods, feelings of long-term hopelessness, pessimism, irritability, guilt, worthlessness, helplessness, loss of interest or enjoyment in hobbies and activities, or low energy. tiredness, moving or speaking slowly, feeling restless or difficult sitting down, difficulty concentrating, remembering, or making decisions, difficulty sleeping, early morning awakening, sleeping excessively, change in appetite and/or weight, or Thoughts of death or suicide, suicide attempts, aches or pains, headaches, cramps, or digestive problems with no obvious physical cause and/or don’t ease even with treatment, and more. Fortunately, recent advances in medicine and psychiatry regularly offer healthcare providers around the world new ways to deal with the specter of mental health disorders.

Ketamine is one of the most promising treatments for depression. mood disordersand the conditions associated with it. Used as an anesthetic in the 1960s, its function as an NDMA receptor antagonist and AMPA receptor agonist unlocks its ability to stimulate neuronal growth, repair and regeneration of neural pathways. When given in precise, carefully controlled doses by a skilled and licensed medical provider, it can provide reduction in symptoms associated with bipolar depression, anxiety, PTSD, and chronic pain. The effectiveness of intravenous ketamine therapy has been verified by reputable research institutes such as Yale University, Mayo Clinic, Mount Sinai Medical School, National Institute of Mental Health, Massachusetts General Hospital, and Stanford University, all of which regularly report a 70% or higher success rate. Intravenous ketamine therapy also helps avoid the side effects of conventional antidepressants, which include constipation, dry mouth, diverted or blurred vision, increased anxiety or aggressiveness, dizziness, weight gain, nausea, decreased sex drive, drowsiness, and insomnia.

MindScape Ketamine & Infusion Therapy can be contacted at (346) 439-9600 or email address info@mindscapeketamine.com for inquiries about intravenous ketamine therapy procedures or to book an appointment. Readers can also visit the Houston website ketamine clinic To fill in the “New Patient Intake” form.


For more information on MindScape Ketamine & Infusion Therapy, PLLC, contact the company here:

Mindscape Ketamine and Infusion Therapy, PLLC
Dr. Kwang Henderson
(832) 501-1813
2211 Norfolk Street Suite # 215
Houston, TX 77098

CONTACT: Dr. Quang H Henderson